Multi-omics analyses reveal altered gut microbial thiamine production in obesity
Frontiers in Microbiology · 17.06.2025 · 16
DOI: 10.3389/fmicb.2025.1516393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 17.06.2025. Verfasst von Yu Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Accumulating evidence highlights the important role of B vitamins in maintaining the balance of gut microbial ecology and metabolism, however, few studies have focused on changes in B vitamins homeostasis in the gut and their associations with disease. This study aims to investigate the potential interplay between B vitamins, gut microbiota, and obesity.
Methods
We conducted an integrated analysis of fecal shotgun metagenomics, fecal metabolome concerning B vitamins and short chain fatty acids (SCFAs), and obese phenotypes in a cohort of 63 participants, including 31 healthy controls and 32 individuals with obesity.
Results
Metabolomic analysis identified significantly lower levels of fecal thiamine in individuals with obesity ( P Wilcoxon < 0.001). Fecal thiamine levels exhibited a positive correlation with HDL-C and a negative correlation with BMI, DBP, fasting serum insulin, HOMA-IR, triglycerides, and propionic acid. Binary logistics regression suggested that fecal thiamine deficiency may be a potential contributor to the onset of obesity (Odds ratio: 0.295). Metagenomic analysis indicated that the microbial composition in individuals with obesity was characterized by a predominance of potential opportunistic pathogens, a loss of complexity, and a decrease in thiamine-producing bacteria. Integrated analysis indicated that thiamine deficiency was positively associated with the depletion of thiamine auxotrophic bacteria in the obese microbiome. Functional analysis revealed that KOs content for enzymes involved in the microbial production of thiamine were significantly lower in obesity, including tRNA uracil 4-sulfurtransferase (ThiI, P Wilcoxon = 0.001) and nucleoside-triphosphatase (NTPCR, P Wilcoxon = 0.006), both of which were positively associated with fecal thiamine.
Conclusion
Our study highlights the impairment of microbial thiamine production and its broad associations with gut microbiota dysbiosis and obesity-related phenotypes. Our findings provide a rationale for developing treatments that utilize thiamine to prevent obesity by modulating gut microbiota.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China.
- School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
- Department of Biochemistry, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
- Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
- Department of Pediatrics, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China.
Zitieren
APA
Xia, Y., Lu, L., Wang, L., Qiu, Y., Liu, X., & Ge, W. (2025). Multi-omics analyses reveal altered gut microbial thiamine production in obesity. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1516393
Vancouver
Xia Y, Lu L, Wang L, Qiu Y, Liu X, Ge W. Multi-omics analyses reveal altered gut microbial thiamine production in obesity. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1516393
BibTeX
@article{Xia2025,
author = {Xia, Yu and Lu, Longya and Wang, Lulu and Qiu, Yanyan and Liu, Xingyin and Ge, Weihong},
title = {Multi-omics analyses reveal altered gut microbial thiamine production in obesity},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1516393}
}
EUVIMED